NYSE:RAD
Delisted

Rite Aid Stock News

etoro logo Buy RAD
*Your capital is at risk
$0.648
+0 (+0%)
At Close: Jan 12, 2024
Drugstore chain Rite Aid said Tuesday it plans to shutter at least 63 stores as it reassesses how many locations it needs in the United States.

Rite Aid To Close More Than 60 Stores

07:50am, Tuesday, 21'st Dec 2021
Rite Aid said it will close 63 stores in a cost-cutting move designed to save money and help the chain be more competitive.
Rite Aid Corp. RAD, +2.90% shares rose 2.4% in Tuesday premarket trading after the pharmacy retailer reported a surprise third-quarter adjusted profit and announced dozens of store closures. Net loss
The shortened holiday week will see less public offerings and earnings from public companies. The week can still bring plenty of trading opportunities with headlines and catalysts. Several public comp
The shortened holiday week will see less public offerings and earnings from public companies. The week can still bring plenty of trading opportunities with headlines and catalysts.
The shares of drugstore chain Rite Aid Corporation (NYSE:RAD) are down 2.2% to trade at $11.80 this afternoon, just ahead of the company's third-quarter earnings report -- due out before the open tom

Rite Aid (RAD) to Release Quarterly Earnings on Tuesday

06:12am, Monday, 20'th Dec 2021 Dakota Financial News
Rite Aid (NYSE:RAD) is set to announce its earnings results before the market opens on Tuesday, December 21st. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. Investors that wish to register for the companys conference call can do so using this link. Rite Aid (NYSE:RAD) last posted its quarterly []
Four companies we have previewed reported quarterly results after markets closed Thursday or before they opened on Friday.

Factors Likely to Influence Rite Aid (RAD) in Q3 Earnings

04:14pm, Thursday, 16'th Dec 2021 Zacks Investment Research
Rite Aid (RAD) is likely to have gained from strength in PBM, RxEvolution strategy and delivery services in Q3. Rising wage costs and drab front-end same-store sales are likely to have been concerns.
Rite Aid (RAD) is likely to have gained from strength in PBM, RxEvolution strategy and delivery services in Q3. Rising wage costs and drab front-end same-store sales are likely to have been concerns.
Radiopharm Theranostics Ltd (ASX:RAD) insider Riccardo Canevari acquired 150,000 shares of the firms stock in a transaction that occurred on Tuesday, December 7th. The stock was acquired at an average price of A$0.32 ($0.23) per share, with a total value of A$47,250.00 ($33,750.00). About Radiopharm Theranostics Rite Aid Corporation is on the front lines of []
Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brokerages forecast that Rite Aid Co. (NYSE:RAD) will announce $6.28 billion in sales for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Rite Aid’s earnings. The highest sales estimate is $6.31 billion and the lowest is $6.25 billion. Rite Aid reported sales of $6.12 billion during the same quarter […]
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE